LDLR and hepatocellular carcinoma: The miRNA hsa-miR-17-5p has been described to be significantly upregulated in hepatocellular carcinoma [35,36], and it has been reported that LDLR was repressed by overexpressing hsa-miR-17-5p in HeLa cells.